Trademark: CHARACTERIZED IMMUNOTHERAPY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
CHARACTERIZED IMMUNOTHERAPY
Click here to search for trademarks similar to CHARACTERIZED IMMUNOTHERAPY
Proof of use for CHARACTERIZED IMMUNOTHERAPY
We do not have any records of a proof of use for CHARACTERIZED IMMUNOTHERAPY at this moment.
Click here to add a proof of use for CHARACTERIZED IMMUNOTHERAPY
Possible trademark infringements of CHARACTERIZED IMMUNOTHERAPY
Basic Information about CHARACTERIZED IMMUNOTHERAPY
- Serial Number
- 85930955
- Filing Date
- 13 May 2013
- Registration Number
- 4676043
- Registration Date
- 20 Jan 2015
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of CHARACTERIZED IMMUNOTHERAPY on the blockchain with WikiTrademarks.io.
- First use of CHARACTERIZED IMMUNOTHERAPY anywhere
- CHARACTERIZED IMMUNOTHERAPY was first used on 20 Nov 2014 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns CHARACTERIZED IMMUNOTHERAPY?
1. SOCIÉTÉ DES PRODUITS NESTLÉ S.A. VEVEY
2. AIMMUNE THERAPEUTICS, INC. BRISBANE CA
3. Allergen Research Corporation San Mateo CA
4. Allergen Research Corporation Menlo Park CA
5. Allergen Research Corporation Menlo Park CA
Correspondent
- Thad Chaloemtiarana
- PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD
- 200 South Wacker Drive, Suite 2900
- CHICAGO IL 60606-5896
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io